Literature DB >> 22390546

LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion.

Qiaozhen Lu1, Vered Padler-Karavani, Hai Yu, Xi Chen, Shiaw-Lin Wu, Ajit Varki, William S Hancock.   

Abstract

Human polyclonal IgG antibodies directly against the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc) are potential biomarkers and mechanistic contributors to cancer and other diseases associated with chronic inflammation. Using a sialoglycan microarray, we screened the binding pattern of such antibodies (anti-Neu5Gc IgG) in several samples of clinically approved human IVIG (IgG). These results were used to select an appropriate sample for a multistep affinity purification of the xeno-autoantibody fraction. The sample was then analyzed via our multienzyme digestion procedure followed by nano liquid chromatography (nanoLC) coupled to linear ion trap-Fourier transform mass spectrometry (LTQ-FTMS). We used characteristic and unique peptide sequences to determine the IgG subclass distribution and thus provided direct evidence that all four IgG subclasses can be generated during a xeno-autoantibody immune response to carbohydrate Neu5Gc-antigens. Furthermore, we obtained a significant amount of sequence coverage of both the constant and variable regions. The approach described here, therefore, provides a way to characterize these clinically significant antibodies, helping to understand their origins and significance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390546      PMCID: PMC4142218          DOI: 10.1021/ac2030893

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  26 in total

Review 1.  Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective.

Authors:  Takashi Angata; Ajit Varki
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

2.  Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry.

Authors:  Dominique de Costa; Ingrid Broodman; Martijn M Vanduijn; Christoph Stingl; Lennard J M Dekker; Peter C Burgers; Henk C Hoogsteden; Peter A E Sillevis Smitt; Rob J van Klaveren; Theo M Luider
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

Review 3.  Protein A chromatography for antibody purification.

Authors:  Sophia Hober; Karin Nord; Martin Linhult
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-10-09       Impact factor: 3.205

4.  Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum.

Authors:  Alex Zhu; Rosa Hurst
Journal:  Xenotransplantation       Date:  2002-11       Impact factor: 3.907

5.  Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells.

Authors:  Dzung H Nguyen; Pam Tangvoranuntakul; Ajit Varki
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator.

Authors:  Haitao Jiang; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2010-07-15       Impact factor: 6.986

7.  Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

Authors:  Vered Padler-Karavani; Nancy Hurtado-Ziola; Minya Pu; Hai Yu; Shengshu Huang; Saddam Muthana; Harshal A Chokhawala; Hongzhi Cao; Patrick Secrest; Dinorah Friedmann-Morvinski; Oded Singer; Darius Ghaderi; Inder M Verma; Yu-Tsueng Liu; Karen Messer; Xi Chen; Ajit Varki; Richard Schwab
Journal:  Cancer Res       Date:  2011-04-19       Impact factor: 12.701

8.  Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.

Authors:  Vered Padler-Karavani; Hai Yu; Hongzhi Cao; Harshal Chokhawala; Felix Karp; Nissi Varki; Xi Chen; Ajit Varki
Journal:  Glycobiology       Date:  2008-07-31       Impact factor: 4.313

9.  Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass.

Authors:  Stephan von Gunten; David F Smith; Richard D Cummings; Stefan Riedel; Sylvia Miescher; Alexander Schaub; Robert G Hamilton; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-05-13       Impact factor: 10.793

10.  Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.

Authors:  Maria Hedlund; Vered Padler-Karavani; Nissi M Varki; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

View more
  14 in total

1.  Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation.

Authors:  Qi Li; Sahar Shaikh; Hayato Iwase; Cassandra Long; Whayoung Lee; Zhongqiang Zhang; Yi Wang; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Xenotransplantation       Date:  2019-02-16       Impact factor: 3.907

2.  A Chemical Biology Solution to Problems with Studying Biologically Important but Unstable 9-O-Acetyl Sialic Acids.

Authors:  Zahra Khedri; An Xiao; Hai Yu; Corinna Susanne Landig; Wanqing Li; Sandra Diaz; Brian R Wasik; Colin R Parrish; Lee-Ping Wang; Ajit Varki; Xi Chen
Journal:  ACS Chem Biol       Date:  2016-12-12       Impact factor: 5.100

3.  Sialic acid speciation using capillary electrophoresis: optimization of analyte derivatization and separation.

Authors:  Zoltan Szabo; Jonathan Bones; Andras Guttman; James Glick; Barry L Karger
Journal:  Anal Chem       Date:  2012-08-29       Impact factor: 6.986

4.  Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts.

Authors:  Linda Scobie; Vered Padler-Karavani; Stephanie Le Bas-Bernardet; Claire Crossan; Josef Blaha; Magda Matouskova; Ralph D Hector; Emanuele Cozzi; Bernard Vanhove; Beatrice Charreau; Gilles Blancho; Ludovic Bourdais; Mariachiara Tallacchini; Juan M Ribes; Hai Yu; Xi Chen; Jitka Kracikova; Ludomir Broz; Jiri Hejnar; Pavel Vesely; Yasuhiro Takeuchi; Ajit Varki; Jean-Paul Soulillou
Journal:  J Immunol       Date:  2013-08-14       Impact factor: 5.422

Review 5.  Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides.

Authors:  Anoopjit Singh Kooner; Hai Yu; Xi Chen
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

6.  Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions.

Authors:  Karen N Barnard; Brynn K Alford-Lawrence; David W Buchholz; Brian R Wasik; Justin R LaClair; Hai Yu; Rebekah Honce; Stefan Ruhl; Petar Pajic; Erin K Daugherity; Xi Chen; Stacey L Schultz-Cherry; Hector C Aguilar; Ajit Varki; Colin R Parrish
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

7.  A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease.

Authors:  Vered Padler-Karavani; Adriana H Tremoulet; Hai Yu; Xi Chen; Jane C Burns; Ajit Varki
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

8.  Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation.

Authors:  Takayuki Yamamoto; Yehua Cui; Diyan Patel; Abhijit Jagdale; Hayato Iwase; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

Review 9.  From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.

Authors:  Chirag Dhar; Aniruddha Sasmal; Ajit Varki
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

Review 10.  Exploration of sialic acid diversity and biology using sialoglycan microarrays.

Authors:  Lingquan Deng; Xi Chen; Ajit Varki
Journal:  Biopolymers       Date:  2013-10       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.